Engineering lymphocyte subsets: Tools, trials and tribulations

Carl H. June, Bruce R. Blazar, James L. Riley

Research output: Contribution to journalReview articlepeer-review

161 Scopus citations

Abstract

Cell-based therapies with various lymphocyte subsets hold promise for the treatment of several diseases, including cancer and disease resulting from inflammation and infection. The ability to genetically engineer lymphocyte subsets has the potential to improve the natural immune response and correct impaired immunity. In this Review we focus on the lymphocyte subsets that have been modified genetically or by other means for therapeutic benefit, on the technologies used to engineer lymphocytes and on the latest progress and hurdles in translating these technologies to the clinic.

Original languageEnglish (US)
Pages (from-to)704-716
Number of pages13
JournalNature Reviews Immunology
Volume9
Issue number10
DOIs
StatePublished - Oct 2009

Fingerprint Dive into the research topics of 'Engineering lymphocyte subsets: Tools, trials and tribulations'. Together they form a unique fingerprint.

Cite this